Labs / Assays & in vitro testing

MindWalk
Victoria, BC, Canada · mindwalkai.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
MindWalk is an antibody discovery company serving pharma, biotech, and academic partners. It runs discovery, development, and optimization programs and also offers AI-enabled biological context software for drug discovery. The company has locations in the USA, Canada, and Belgium.
Their website has a general contact form; we send your quote request through it.
What they offer
Antibody discovery programs
End-to-end antibody discovery, development, and optimization customized to a target.
B cell Select® discovery
Functional antibody discovery platform with >98% discovery success rate stated by the company.
B cell Llama™ VHH discovery
Direct B cell VHH discovery platform for bispecific, multispecific, and other therapeutic formats.
Hybridoma discovery
Antibody discovery using hybridoma-based campaigns.
Yeast display discovery
Antibody discovery using yeast display.
Therapeutic antibodies
Discovery support for therapeutic antibody programs.
Anti-drug & anti-idiotype antibodies
Discovery and development support for anti-drug and anti-idiotype antibodies.
Diagnostic antibodies
Discovery and development support for diagnostic antibodies.
Protein engineering & production
Protein engineering and production services.
ReefIQ™
Biological context layer that connects discovery data and adds biological meaning for AI drug discovery.
LensAI™
AI analysis platform used in programs for epitope mapping, paratyping, developability, immunogenicity, and candidate evaluation.
What they work on
- Modalities
- Antibody, Bispecific, Peptide, Cell therapy
- Species and models
- camelid immune repertoire
- Assays and studies
- epitope mapping, paratyping, developability, immunogenicity, candidate evaluation, anti-drug-antibody risk prediction
- Scale and capacity
- Over 20 publicly disclosed client antibodies have entered the clinic, Ten in the clinic today, Four first in class, 3,000 times
- Therapeutic areas
- drug discovery
- Type
- CRO
- Sites
- Austin, USA · Fargo, USA · Victoria, Canada · Diepenbeek, Belgium
- Quality
- Patented HYFT® technology (EP3881326)
- Address
- 823 Congress Ave Suite 300 Austin, TX 78701, USA
- Founded
- 2019
Similar labs. Creative Biolabs, Kyinno Bio, Olympic Protein Technologies, Oncodesign Services
Found in a contract services directory. Listing built from mindwalkai.com. Work here? Claim this listing.